INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING

Board & Shareholder Meetings View source PDF

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Eris Lifesciences has informed the stock exchanges about a scheduled meeting with Capital Research on May 2, 2025, in a virtual format. This is a routine disclosure under SEBI's Listing Obligations and Disclosure Requirements Regulations. The company has clarified that only publicly available information will be discussed during the interaction, and no unpublished price sensitive information (UPSI) will be shared. The schedule is indicative and may change due to unforeseen developments.

Likely market impact

This is a standard regulatory disclosure with no direct impact on stock price, though engagement with Capital Research — a major global investment firm — signals continued institutional interest in the company.